comparemela.com

Page 7 - Lawrence Blatt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aligos Therapeutics Announces Research Collaboration and Development Agreement with Xiamen Amoytop Biotech Co Ltd for Use of Aligos Oligonucleotide Platform for the Treatment of Liver Diseases

SOUTH SAN FRANCISCO, Calif., May 12, 2023 Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver. | May 12, 2023

Sun liCorey davisAmy jobeLawrence blattXiamen amoytop biotech coAligos therapeutics incLifesci communicationsExchange commissionExchange commission onXiamen amoytop biotechGreater chinaSecurities litigation reform actAligo quarterly reportAligos therapeuticsNc stock exchangePress release

Aligos Therapeutics to Present Data from Chronic Hepatitis B and Hepatocellular Carcinoma Programs at the European Association for the Study of the Liver (EASL) Congress 2023

12.04.2023 - SOUTH SAN FRANCISCO, Calif., April 11, 2023 (GLOBE NEWSWIRE) - Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral . Seite 1

Lawrence blattAligos therapeutics incEuropean associationScientific presentations

Aligos Therapeutics to Present Data from Chronic Hepatitis

SOUTH SAN FRANCISCO, Calif., April 11, 2023 (GLOBE NEWSWIRE) Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company.

Jin hongLawrence blattAlina jucovCorey davisKusum guptaJinlin houYannick debingAmy jobeTongfei wuExchange commissionExchange commission onAligos therapeutics incLifesci communicationsEuropean associationScientific presentationsSecurities litigation reform act

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

Jinlin houCorey davisKusum guptaYannick debingAmy jobeJin hongAlina jucovLawrence blattTongfei wuLifesci communicationsExchange commissionAligos therapeutics incExchange commission onEuropean associationScientific presentationsSecurities litigation reform act

Aligos Therapeutics Presents Clinical Data from NASH Program at the 2023 Paris Hepatology Conference

SOUTH SAN FRANCISCO, Calif., March 29, 2023 Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in. | March 29, 2023

France generalLawrence blattAmy jobeMattheww mcclureCorey davisAligos therapeutics incExchange commissionExchange commission onLifesci communicationsParis hepatology conferenceScientific presentationsFavorable safetyPharmacokinetic profileDose proportionally lowers lipid biomarkersChief medical officerDrugs pipeline presented

vimarsana © 2020. All Rights Reserved.